MAOS and medicinal chemistry: Some important examples from the last years

Molecules

Volumn 16, Issue 11, 2011, Pages 9274-9297

  Nascimento Jr , Nailton M ^a   Kümmerle, Arthur E ^b   Barreiro, Eliezer J ^a   Fraga, Carlos A M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Bioactive compounds; Drug discovery; Medicinal chemistry; Microwave irradiation

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; HETEROCYCLIC COMPOUND;

ANIMAL; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; HUMAN; METHODOLOGY; MICROWAVE RADIATION; NEGLECTED DISEASE; PARASITOSIS; SYNTHESIS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CHEMISTRY TECHNIQUES, SYNTHETIC; CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; HETEROCYCLIC COMPOUNDS; HUMANS; MICROWAVES; MOLECULAR STRUCTURE; NEGLECTED DISEASES; PARASITIC DISEASES;

EID: 82255183267     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16119274     Document Type: Article

References (117)

1. Gedye, R.; Smith, F.; Westaway, K.; Ali, H.; Baldisera, L.; Laberge, L.; Rousell, J. The use of microwave ovens for rapid organic synthesis. Tetrahedron Lett. 1986, 27, 279-282.
2. Giguere, R.J.; Bray, T.L.; Duncan, S.M.; Majetich, G. Application of commercial microwave ovens to organic synthesis. Tetrahedron Lett. 1986, 27, 4945-4948.
3. Lidström, P.; Tierney, J.; Wathey, B.; Westman, J. Microwave assisted organic synthesis - a review. Tetrahedron 2001, 57, 9225-9283. (Pubitemid 33016768)
4. Bougrin, K.; Loupy, A.; Soufiaoui, M. Microwave-assisted solvent-free heterocyclic synthesis. J. Photochem. Photobiol. C Photochem. Rev. 2005, 6, 139-167. (Pubitemid 41597528)
5. Pérez-Picaso, L.; Escalante, J.; Olivo, H.F.; Rios, M.Y. Efficient microwave assisted syntheses of 2,5-Diketopiperazines in aqueous media. Molecules 2009, 14, 2836-2849.
6. Hügel, H.M. Microwave multicomponent synthesis. Molecules 2009, 14, 4936-4972.
7. Kappe, C.O. High-speed combinatorial synthesis utilizing microwave irradiation. Curr. Opin. Chem. Biol. 2002, 6, 314-320. (Pubitemid 34522056)
8. Kong, L.; Lv, X.; Lin, K.; Liu, X.; Zhou, Y.; Jia, Y. Efficient synthesis of imidazoles from aldehydes ans 1,2-Diketones under superheating continuous by using a continuous flow microreactor system under pressure. Org. Proc. Res. Dev. 2010, 14, 902-904.
9. Schmink, J.R.; Kormos, C.M.; Devine, W.G.; Leadbeater, N.E. Exploring the scope for scale up of organic chemistry using a large batch microwave reactor. Org. Proc. Res. Dev. 2010, 14, 205-214.
10. Patil, S.A.; Patil, R.; Miller, D.D. Microwave-assisted synthesis of medicinally relevant indoles. Curr. Med. Chem. 2011, 18, 615-637.
11. Zhao, Z.; Wisnoski, D.D.; Wolkenberg, S.E.; Leister, W.H.; Wang, Y.; Lindsley, C.W. General microwave-assisted protocols for the expedient synthesis of quinoxalines and heterocyclic pyrazines. Tetrahedron Lett. 2004, 45, 4873-4876. (Pubitemid 38738838)
12. Chilin, A.; Marzaro, G.; Zanatta, S.; Guiotto, A. A microwave improvement in the synthesis of the quinazoline scaffold. Tetrahedron Lett. 2007, 48, 3229-3231. (Pubitemid 46527753)
13. Reichelt, A.; Filsey, J.R.; Rzasa, R.M.; Thiel, O.R.; Achmatowicz, M.M.; Larsen, R.D.; Zhang, D. Palladium-catalyzed chemoselective monoarylation of hydrazides for the synthesis of [1,2,4]triazolo[4,3-a]pyridines. Org. Lett. 2009, 12, 792-795.
14. Lucas, R.; Vergnaud, J.; Teste, K.; Zerrouk, R.; Sol, V.; Krausz, P. A facile and rapid iodine-catalyzed meso-tetraphenylporphyrin synthesis using microwave activation. Tetrahedron Lett. 2008, 49, 5537-5539.
15. Yeung, K.-S.; Farkas, M.E.; Kadow, J.F.; Meanwell, N.A. A base-catalyzed, direct synthesis of 3,5-disubstituted 1,2,4-triazoles from nitriles and hidrazides. Tetrahedron Lett. 2005, 46, 3429-3432. (Pubitemid 40523530)
16. Adib, M.; Jahromi, A.H.; Tavoosi, N.; Mahdavi, H.; Bijanzadeh, H.R. Microwave-assisted one efficient, one pot, three-multicomponent synthesis of 3,5-disubstituted 1,2,4-oxadiazoles under free-solvent conditions. Tetrahedron Lett. 2006, 47, 2965-2967.
17. Andrade, M.M.; Barros, M.T. Fast synthesis of N-Acylhydrazones employing a microwave assisted neat protocol. J. Comb. Chem. 2010, 12, 245-247.
18. Baxendale, I.R.; Ley, S.V. Polymer-supported reagents for multi-step organic synthesis: Application to the synthesis of sidenafil. Bioorg. Med. Chem. Lett. 2000, 10, 1983-1986. (Pubitemid 30663355)
19. SCOPUS. Available online: http://www.scopus.com (accessed on 13 September 2011).
20. Kappe, C.O.; Dallinger, D. The impact of microwave synthesis on drug discovery. Nat. Rev. Drug Discov. 2006, 5, 51-64.
21. Larhed, M.; Hallberg, A. Microwave-assisted high-speed chemistry: A new technique in drug discovery. Drug Discov. Today 2001, 6, 406-416. (Pubitemid 32328295)
22. Shipe, W.D.; Wolkenberg, S.E.; Lindsley, C.W. Accelerating lead development by microwaveenhanced medicinal chemistry. Drug Discov. Today Technol. 2005, 2, 155-161. (Pubitemid 40946323)
23. World Health Organization. Available online: http://www.who.int/cancer/ en/ (accessed on 1 February 2011).
24. Noble, M.E.M.; Endicott, J.A.; Johnson, L.N. Protein kinase inhibitors: Insights into drug design from structure. Science 2004, 303, 1800-1805. (Pubitemid 38374863)
25. Li, Q.; Zhu, G.D. Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer. Curr. Top. Med. Chem. 2002, 2, 939-971.
26. Lindsley, C.W.; Zhao, Z.; Leister, W.H.; Robinson, R.G.; Barnett, S.F.; Defeo-Jones, D.; Jones, R.E.; Hartman, G.D.; Huff, J.R.; Huber, H.E.; et al. Allosteric Akt (PKB) inhibitors: Discovery and SAR of isozyme selective inhibitors. Bioorg. Med. Chem. Lett. 2005, 15, 761-764. (Pubitemid 40143162)
27. Cheng, J.Q.; Lindsley, C.W.; Cheng, G.Z.; Yang, H.; Nicosia, S.V. The Akt/PKB pathway: Molecular target for cancer drug discovery. Oncogene 2005, 24, 7482-7492. (Pubitemid 41637988)
28. Barnett, S.F.; Bilodeau, M.T.; Lindsley, C.W. The Akt/PKB family of protein kinases: A review of small molecule inhibitors and progress towards target validation. Curr. Top. Med. Chem. 2005, 5, 109-125. (Pubitemid 40514509)
29. Caldwell, J.J.; Davies, T.G.; Donald, A.; McHardy, T.; Rowlands, M.G.; Aherne, G.W.; Hunter, L.K.; Taylor, K.; Ruddle, R.; Raynaud, F.I.; et al. Identification of 4-(4-aminopiperidin- 1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration. J. Med. Chem. 2008, 51, 2147-2157. (Pubitemid 351503270)
30. Caldwell, J.J.; Cheung, K.-M.; Collins, I. Synthesis of 4-(cyclic dialkylamino)-7-azaindoles by microwave heating of 4-halo-7-azaindoles and cyclic secondary amines. Tetrahedron Lett. 2007, 48, 1527-1529. (Pubitemid 46177155)
31. Hajdúch, M.; Havlíèek, L.; Vesel, J.; Novotn, R.; Mihàl, V.; Strnad, M. Synthetic cyclin-dependent kinase inhibitors: New generation of potent anti-cancer drugs. Adv. Exp. Med. Biol. 1999, 457, 341-353. (Pubitemid 129735328)
32. Sherr, C.J. Cancer cell cycles. Science 1996, 274, 1672-1677.
33. López-Cara, L.C.; Conejo-García, A.; Marchal, J.A.; MacChione, G.; Cruz-López, O.; Boulaiz, H.; García, M.A.; Rodríguez-Serrano, F.; Ramírez, A.; Cativiela, C.; et al. New (RS)-benzoxazepinpurines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(pnitrobenzenesulfonyl)- 1,2,3,5-tetrahydro-4,1- benzoxazepin-3-yl]-9H-purine. Eur. J. Med. Chem. 2011, 46, 249-258.
34. Díaz-Gavilán, M.; Rodríguez-Serrano, F.; Gómez-Vidal, J.A.; Marchal, J.A.; Aránega, A.; Gallo, M.A.; Espinosa, A.; Campos, J.M. Synthesis of tetrahydrobenzoxazepine acetals with electron-withdrawing groups on the nitrogen atom. Novel scaffolds endowed with anticancer activity against breast cancer cells. Tetrahedron 2004, 60, 11547-11557. (Pubitemid 39505321)
35. a ed.; Elsevier: Rio de Janeiro, Brazil, 2007.
36. Dinarello, C.A. Proinflammatory cytokines. Chest 2000, 118, 503.
37. Tillie-Leblond, I.; Pugin, J.; Marquette, C.-H.; Lamblin, C.; Saulnier, F.; Brichet, A.; Wallaert, B.; Tonnel, A.-B.; Gosset, P. Balance between proinflammatory cytokinesand their inhibitors in bronchial lavage from patients with status asthmaticus. Am. J. Respir. Crit. Care Med. 1999, 159, 487-494. (Pubitemid 29084870)
38. Checker, R.; Sharma, D.; Sandur, S.K.; Khanam, S.; Poduval, T.B. Anti-inflammatory effects of plungabin are mediated by inhibition of NF-κB activation in lymphocytes. Int. Immunopharmacol. 2009, 9, 949-958.
39. Ferreira, M.A.D.; Nunes, O.D.R.H.; Fontenele, J.B.; Pessoa, O.D.L.; Lemos, T.L.G.; Viana, G.S.B. Analgesic and anti-inflammatory activities of a fraction rich in oncocalyxone A isolated from Auxemma oncocalyx. Phytomedicine 2004, 11, 315-322. (Pubitemid 38657461)
40. Phutdhawong, W.S.; Ruensamran, W.; Phutdhawong, W.; Taechowisan, T. Synthesis of 1,6,7,8-tetrahydro-naphtho[2,3-d]-azepino[4,5b]indole-9,14-diones and their inhibitory effects on pro-inflammatory cytokines. Bioorg. Med. Chem. Lett. 2009, 19, 5753.
41. Phutdhawong, W.; Buddhasukh, D. Facile microwave-assisted synthesis of 9,10-Dihydro-9,10- ethanoanthracene-11-carboxylic acid methyl ester. Molecules 2005, 10, 1409-1412. (Pubitemid 43021254)
42. Clark-Lewis, I.; Mattioli, I.; Gong, J.H.; Loetscher, P. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J. Biol. Chem. 2003, 278, 289-295. (Pubitemid 36043575)
43. Qin, S.; Rottman, J.B.; Myers, P.; Kassam, N.; Weinblatt, M.; Loetscher, M.; Koch, A.E.; Moser, B.; Mackay, C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 1998, 101, 746-754. (Pubitemid 28096070)
44. Lazzeri, E.; Romagnani, P. CXCR3-bindind chemokines: Novel multifunctional therapeutic targets. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2005, 5, 109-118. (Pubitemid 40394308)
45. Salomon, I.; Netzer, N.; Wildbaum, G.; Schif-Zuck, S.; Maor, G.; Karin, N. Targeting the function of IFN-γ-Inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 2002, 169, 2685-2693. (Pubitemid 34921017)
46. Hancock, W.W.; Lu, B.; Gao, W.; Csizmadia, V.; Faia, K.; King, J.A.; Smiley, S.T.; Ling, M.; Gerard, N.P.; Gerard, C. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 2000, 192, 1515-1520.
47. Donnelly, L.E.; Barnes, P.J. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol. Sci. 2006, 27, 546-553. (Pubitemid 44374756)
48. Knight, R.L.; Allen, D.R.; Birch, H.L.; Chapman, G.A.; Galvin, F.C.; Jopling, L.A.; Lock, C.J.; Meissner, J.W.G.; Owen, D.A.; Raphy, G.; et al. Development of CXCR3 antagonists. Part 4: Discovery of 2-amino-(4-tropinyl) quinolines. Bioorg. Med. Chem. Lett. 2008, 18, 629-633.
49. Maes, B.U.W.; Loones, K.T.J.; Lemière, G.L.F.; Dommisse, R.A. Rapid palladium-catalyzed aminations of aryl chlorides with aliphatic amines under temperature-controlled microwave heating. Synlett 2003, 12, 1822-1825. (Pubitemid 37271783)
50. Hardman, J.; Limbird, L.E. Goodman & Gilman's the Pharmacological Basis of Therapeutcs, 10th ed.; McGraw-Hill: New York, NY, USA, 2001.
51. Schmid, M.B. Novel approaches to the discovery of antimicrobial agents. Curr. Opin. Chem. Biol. 1998, 2, 529-534. (Pubitemid 128645707)
52. Rollas, S.; Küçükgüzel, S.G. Biological activities of hydrazone derivatives. Molecules 2007, 12, 1910-1939.
53. Fraga, C.A.M.; Barreiro, E.J. Medicinal chemistry of N-Acylhydrazones: New lead-compounds of analgesic, antiinflammatory and antithrombotic drugs. Curr. Med. Chem. 2006, 13, 167-198.
54. Ajani, O.O.; Obafemi, C.A.; Nwinyi, O.C.; Akinpelu, D.A. Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives. Bioorg. Med. Chem. 2010, 18, 214-221.
55. Amir, M.; Kumar, H.; Khan, S.A. Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents. Bioorg. Med. Chem. Lett. 2008, 18, 918-922. (Pubitemid 351193005)
56. Chakrabarthi, K.J.E.; Richard, J.G.; Peter, T.; Janette, H.; Terrence, H.A. 5-Acyl-3-substituted benzofuran-2(3H)-ones as potential antiinflammatory agents. J. Med. Chem. 1987, 30, 1663-1668.
57. Akbas, E.; Berber, I. Antibacterial and antifungal activities of new pyrazolo[3,4-d]pyridazin derivatives. Eur. J. Med. Chem. 2005, 40, 401-405. (Pubitemid 40460302)
58. Rostom, S.A.F.; Shalaby, M.A.; El-Demellawy, M.A. Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3- carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HVC agents. Eur. J. Med. Chem. 2003, 38, 959-974. (Pubitemid 37452423)
59. Manna, K.; Agrawal, Y.K. Microwave assisted synthesis of new indophenazine 1,3,5-trisubstruted pyrazoline derivatives of benzofuran and their antimicrobial activity. Bioorg. Med. Chem. Lett. 2009, 19, 2688-2692.
60. Weiss, U. Hepatitis C. Nature 2005, 436, 929-978.
61. Feld, J.J.; Hoofnagle, J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005, 436, 967-972. (Pubitemid 41191673)
62. Zhu, R.; Wang, M.; Xia, Y.; Qu, F.; Neyts, J.; Peng, L. Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication. Bioorg. Med. Chem. Lett. 2008, 18, 3321-3327. (Pubitemid 351721004)
63. Zhu, R.; Qu, F.; Quéléver, G.; Peng, L. Direct synthesis of 5-aryltriazole acyclonucleosides via Suzuki coupling in aqueous solution. Tetrahedron Lett. 2007, 48, 2389-2393.
64. van Compernolle, S.E.; Wiznycia, A.V.; Rush, J.R.; Dhanasekaran, M.; Baures, P.W.; Todd, S.C. Small molecule inhibition of hepatitis C virus E2 binding to CD81. Virology 2003, 314, 371-380. (Pubitemid 37158015)
65. Holzer, M.; Ziegler, S.; Albrecht, B.; Kronenberger, B.; Kaul, A.; Bartenschlager, R.; Kattner, L.; Klein, C.D.; Hartmann, R.W. Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: Synthesis and structure optimization. Molecules 2008, 13, 1081-1110.
66. Ziegler, S.; Kronenberger, B.; Albrecht, B.A.-M.; Kaul, A.; Gamer, A.-L.; Klein, C.D.; Hartmann, R.W. Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitors. J. Biomol. Screen. 2009, 14, 620-626.
67. Carr, A.; Clyde, R. Piperidinderivate. D.E. Patent 25.06.770, 1975.
68. de Clercq, E. Recent highlights in the development of new antiviral drugs. Curr. Opin. Microb. 2005, 8, 552-560. (Pubitemid 41355035)
69. Richman, D.D. Antiviral drug resistance. Antivir. Res. 2006, 71, 117-121. (Pubitemid 44223755)
70. Smejkal, J.; Sorm, F. Nucleic acid components and their analogues. 53. Preparation of 1-(2-deoxy- l-ribofuranosyl)thymine (l-thymidine). Collect. Czech. Chem. Commun. 1964, 29, 2809-2813.
71. Maury, G. The enantioselectivity of enzymes involved in current antiviral therapy using nucleoside analogues: A new strategy? Antivir. Chem. Chemother. 2000, 11, 165-190.
72. Focher, F.; Spadari, S.; Maga, G. Antivirals at the mirror: The lack of stereospecificity of some viral and human enzymes offers novel opportunities in antiviral drug development. Curr. Drug Targets Infect. Disord. 2003, 3, 41-53. (Pubitemid 36304946)
73. Beach, J.W.; Jeong, L.S.; Alves, A.J.; Pohl, D.; Kim, H.O.; Chang, C.-N.; Doong, S.-L.; Schinazi, R.F.; Cheng, Y.-C.; Chu, C.K. Synthesis of enantiomerically pure (2'R,5'S)-(-)-1-[2- (hydroxymethyl)oxathiolan-5-yl] cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J. Org. Chem. 1992, 57, 2217-2219.
74. Cameron, J.M.; Collins, P.; Daniel, M.; Storer, R.; Wilcox, P. Lamivudine. Drugs Future 1993, 18, 319-323.
75. Schinazi, R.F.; Lloyd, R.M., Jr.; Nguyen, M.-H.; Cannon, D.L.; McMillan, A.; Ilksoy, N.; Chu, C.K.; Liotta, D.C.; Bazmi, H.Z.; Mellors, J.W. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob. Agents Chemother. 1993, 37, 875-881. (Pubitemid 23096894)
76. Zhang, H.-W.; Detorio, M.; Herman, B.D.; Solomon, S.; Bassit, L.; Nettles, J.H.; Obikhod, A.; Tao, S.-J.; Mellors, J.W.; Sluis-Cremer, N.; et al. Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides. Eur. J. Med. Chem. 2011, 46, 3832-3844.
77. Bookser, B.C.; Raffaele, N.B. High-throughput five minute microwave accelerated glycosylation approach to the synthesis of nucleoside libraries. J. Org. Chem. 2007, 72, 173-179. (Pubitemid 46068217)
78. Pepin, J.; Meda, H.A. The epidemiology and control of human African trypanosomiasis. Adv. Parasitol. 2001, 49, 71-132. (Pubitemid 32641453)
79. Barrett, M.P.; Burchmore, R.J.S.; Stich, A.; Lazzari, J.O.; Frasch, A.C.; Cazzulo, J.J.; Krishna, S. The trypanosomiases. Lancet 2003, 362, 1469-1480. (Pubitemid 37352887)
80. Rodgers, J.J. Human African trypanosomiasis, chemotherapy and CNS disease. J. Neuroimmunol. 2009, 211, 16-22.
81. Kennedy, P.G.E. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann. Neurol. 2008, 64, 116-126.
82. Denise, H.; Barrett, M.P. Uptake and mode of action of drugs used against sleeping sickness. Biochem. Pharmacol. 2001, 61, 1-5. (Pubitemid 32013956)
83. Knockaert, M.; Wieking, K.; Schmitt, S.; Leost, M.; Grant, K.M.; Mottram, J.C.; Kunick, C.; Meijer, L. Intracellular targets of paullones: Identification following affinity purification on immobilized inhibitor. J. Biol. Chem. 2002, 277, 25493-25501. (Pubitemid 34951864)
84. Clark, R.L.; Carter, K.C.; Mullen, A.B.; Coxon, G.D.; Owusu-Dapaah, G.; McFarlane, E.; Duong Thi, M.D.; Mackay, S.P. Identification of the benzodiazepines as a new class of antileishmanial agent. Bioorg. Med. Chem. Lett. 2007, 17, 624-627. (Pubitemid 46108572)
85. Spencer, J.; Rathnam, R.P.; Harvey, A.L.; Clements, C.J.; Clark, R.L.; Barrett, M.P.; Wong, P.E.; Male, L.; Coles, S.J.; MacKay, S.P. Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity. Bioorg. Med. Chem. 2011, 19, 1802-1815.
86. Spencer, J.; Anjum, N.; Patel, H.; Rathnam, R.P.; Verma, J. Molybdenum hexacarbonyl and DBU reduction of nitro compounds under microwave irradiation. Synlett 2007, 13, 2557-2558. (Pubitemid 47597161)
87. Spencer, J.; Rathnam, R.P.; Patel, H.; Anjum, N. Microwave mediated reduction of heterocycle and fluorine containing nitroaromatics with Mo(CO)6 and DBU. Tetrahedron 2008, 64, 10195-10200.
88. World Malaria Report 2008; World Health Organization: Geneva, Switzerland, 2008.
89. White, N.J.J. Antimalarial drug resistance. Clin. Invest. 2004, 113, 1084-1092.
90. Orrling, K.M.; Marzahn, M.R.; Gutiérrez-de-Terán, H.; Åqvist, J.; Dunn, B.M.; Larhed, M. Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases. Bioorg. Med. Chem. 2009, 17, 5933-5949.
91. Ekegren, J.K.; Gising, J.; Wallberg, H.; Larhed, M.; Samuelsson, B.; Hallberg, A. Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold. Org. Biomol. Chem. 2006, 4, 3040-3043. (Pubitemid 44186848)
92. Chappuis, F.; Sundar, S.; Hailu, A.; Ghalib, H.; Rijal, S.; Peeling, R.W.; Alvar, J.; Boelaert, M. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? Nat. Rev. Microbiol. 2007, 5, S7-S16. (Pubitemid 350011772)
93. Sands, M.; Kron, M.A.; Brown, R.B. Pentamidine: A review. Rev. Infect. Dis. 1985, 7, 625-634.
94. Bray, P.G.; Barrett, M.P.; Ward, S.A.; de Koning, H.P. Pentamidine uptake and resistance in pathogenic protozoa: Past, present and future. Trends Parasitol. 2003, 19, 232-239. (Pubitemid 36588598)
95. Berman, J.D. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 1997, 24, 684-703. (Pubitemid 27143564)
96. Castro, M. Treatment and prophylaxis of pneumocystis carinii pneumonia. Semin. Respir. Infect. 1998, 13, 296-303. (Pubitemid 28560097)
97. Burri, C. Chemotherapy against human African trypanosomiasis: Is there a road to success? Parasitology 2010, 137, 1987-1994.
98. Oliveira, L.F.; Schubach, A.O.; Martins, M.M.; Passos, S.L.; Oliveira, R.V.; Marzochi, M.C.; Andrade, C.A. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the new world. Acta Trop. 2011, 118, 87-96.
99. Fairlamb, A.H. Chemotherapy of human African trypanosomiasis: Current and future prospects. Trends Parasitol. 2003, 19, 488-494. (Pubitemid 37329657)
100. Zolek, T.; Maciejewska, D. Theoretical models of pentamidine analogs activity based on their DNA minor groove complexes. Eur. J. Med. Chem. 2010, 45, 1991-1999.
101. Moreno, T.; Pous, J.; Subirana, J.A.; Campos, J.L. Coiled-coil conformation of a pentamidine-DNA complex. Acta Crystallorgr. D Biol. Crystallogr. 2010, 66, 251-257.
102. Thuita, J.K.; Karanja, S.M.; Wenzler, T.; Mdachi, R.E.; Ngotho, J.M.; Kagira, J.M.; Tidwell, R.; Brun, R. Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis. Acta Trop. 2008, 108, 6-10.
103. Paloque, L.; Bouhlel, A.; Curti, C.; Dumtre, A.; Verhaeghe, P.; Azas, N.; Vanelle, P. Synthesis and evaluation of monoamidoxime derivatives: Toward new antileishmanial compounds. Eur. J. Med. Chem. 2011, 46, 2984-2991.
104. Knol - A unit of knowledge. Available online: http://knol.google.com/k/ krishan-maggon/globalbrain- drugs-market-review-2008/3fy5eowy8suq3/1# (accessed on 15 July 2011).
105. Korzh, M. The efficacy and safety of zolpidem over 12 months in patient with low back pain and chronic insomnia. Sleep Med. 2007, 8, 578.
106. Yogeeswari, P.; Menon, N.; Semwal, A.; Arjun, M.; Sriram, D. Discovery of mole cules for the treatment of neuropathic pain: Synthesis, antiallodynic and antihyperalgesic activities of 5-(4-nitrophenyl0furoic-2-acid hydrazones. Eur. J. Med. Chem. 2011, 46, 2964-2970.
107. Kummerle, A.E.; Vieira, M.M.; Schmitt, M.; Miranda, A.L.P.; Fraga, C.A.M.; Bourguignon, J.-J.; Barreiro, E.J. Design, synthesis and analgesic properties of novel conformationally-restricted N-acylhydrazones. Eur. J. Med. Chem. 2009, 19, 4963-4966.
108. Menegatti, R.; Silva, G.M.S.; Zapata-Sudo, G.; Raimundo, J.M.; Sudo, R.T.; Barreiro, E.J.; Fraga, C.A.M. Design, synthesis and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile. Bioorg. Med. Chem. 2006, 14, 632-640. (Pubitemid 41767567)
109. Mendes, T.C.F.; Raimundo, J.M.; Nascimento-Junior, N.M.; Fraga, C.A.M.; Barreiro, E.J.; Sudo, R.T.; Zapata-Sudo, G. Sedation and antinociception induced by a new pyrazolo[3,4- b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors. Pharmacol. Biochem. Behav. 2009, 94, 70-74.
110. Tsuji, R.; Isobe, N.; Kawasaki, H. Mechanism of prolongation of pentobarbital-induced sleeping time by empenthrin in mice. Toxicology 1996, 108, 185-190. (Pubitemid 26149999)
111. Mora, S.; Diaz-Veliz, G.; Lungentrass, H.; García-Gonzáles, M.; Coto-Morales, T.; Poletti, C.; de Lima, T.C.; Herrera-Ruiz, M.; Tortoriello, J. Central nervous system activity of the hydroalcocholic extract of Casimiroa edulis in rat and mice . J. Ethnopharmacol. 2005, 97, 191-197. (Pubitemid 40222016)
112. Dundee, J.W.; Halliday, N.J.; Harper, K.W.; Brogden, R.N. Midazolan a review of its pharmacological properties and therapeutic use. Drugs 1984, 28, 519-543. (Pubitemid 15211797)
113. Kuraishi, Y.; Harada, Y.; Aratani, S.; Satoh, M.; Takagi, H. Separate involvement of the spinal noradrenergic and serotoninergic system in morphine analgesia: The differences in mechanical and thermal algesic tests. Brain Res. 1983, 273, 245-252. (Pubitemid 13039713)
114. Nascimento-Júnior, N.M.; Mendes, T.C.F.; Leal, D.M.; Corrêa, C.M.N.; Sudo, R.T.; Zapata-Sudo, G.; Bareiro, E.J.; Fraga, C.A.M. Microwave assisted-synthesis and structure-activity relatioships of neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives. Bioorg. Med. Chem. Lett. 2010, 20, 74-77.
115. Díaz-Ortiz, A.; Carrilo, J.R.; Gómez-Escalonilla, M.J.; de La Hoz, A.; Moreno, A.; Prieto, P. First diels-alder reaction of pyrazolil imides under microwave irradiation. Synlett 1998, 10, 1069-1070. (Pubitemid 128703313)
116. Díaz-Ortiz, A.; de La Hoz, A.; Langa, F. Microwave irradiation in free-solvent conditions: An eco-friendly methodology to prepare indazoles, pyrazolopyridines and bipyrazoles by cycloaddition reactions. Green Chem. 2000, 2, 165-172.
117. Díaz-Ortiz, A.; Carrilo, J.R.; Cossio, F.P.; Gómez- Escalonila, M.J.; de La Hoz, A.; Moreno, A.; Prieto, P. Synthesis of pyrazolo[3,4-b]pyridines by cycloaddition reactions under microwave irradiation. Tetrahedron 2000, 56, 1569-1577. (Pubitemid 30143603)